期刊文献+

经直肠三维超声检测前列腺特异性抗原相关参数诊断前列腺癌的价值 被引量:3

Study of prostate specific antigen relevant parameters in prostate cancer by three-dimensional transrectal ultrasonography
原文传递
导出
摘要 目的 探讨经直肠三维超声与血清前列腺特异性抗原(PSA)相关参数前列腺特异抗原密度(PSAD)、前列腺移行区抗原密度(PSAT)、游离前列腺特异抗原百分比和前列腺特异抗原密度的比值[(F/T)/PSAD]诊断前列腺癌的价值.方法 血清PSA位于4~20μg/L之间的患者78例,应用经直肠三维超声检测前列腺体积和移行区体积,分别计算出PSA相关参数PSAD、PSAT、(F/T)/PSAD.经直肠超声引导下前列腺穿刺活检,获得病理诊断.结果 前列腺癌组27例,前列腺增生组51例,PSAD、PSAT、(F/T)/PSAD在前列腺癌和前列腺增生组中的差异有统计学意义(P〈0.05),诊断前列腺癌的ROC曲线下面积分别为 0.736、0.760、0.800.各参数诊断前列腺癌的合理截点分别为:PSAD〉0.20、PSAT〉0.33、(F/T)/PSAD〈0.8.结论 血清PSA在4~20μg/L时,PSAD、PSAT、(F/T)/PSAD对前列腺癌和前列腺增生的鉴别有重要参考价值.通过经直肠三维超声计算前列腺体积得出的参数更可靠. Objective To investigate the utility of serum prostate specific antigen(PSA) density (PSAD),prostate antigen transition zone density(PSAT) and the ratio of free/total PSA with PSAD [(F/T)/PSAD] in the diagnosis of prostatic carcinoma (PCa) by three-dimensional ultrasonography.Methods Seventy-eight patients (serum prostate-specific antigen between 4-20 μg/L ) were involved.The prostatic volume and its transition zone volume were measured by three-dimensional ultrasonography.Then the relative parameters of PSA [PSAD,PSAT and (F/T)/PSAD] were calculated.Pathologic types were determined by using needle biopsy of prostate.Results Among them,27 patients were suffering from PCa,while the other 51 benign prostate hypertrophy (BPH).The difference of PSAD,PSAT and (F/T)/PSAD between PCa and BPH had arrived statistical significance (P〈0.05).Proportions under the PCa curves were 0.736,0.760,0.800 respectively.Considering both sensitivity and specificity,a cutoff was recommanded:PSAD〉0.20,PSAT〉0.33,(F/T)/PSAD〈0.8.Conclusions When the serum PSA level is between 4 μg/L and 20 μg/L,PSAD,PSAT and (F/T)/PSAD are of significant value to differentiate PCa from benign prostatic hyperplasia patients.The data are more reliable if prostatic volume are calculated by three-dimensional transrectal ultrasonography.
出处 《中华超声影像学杂志》 CSCD 北大核心 2011年第7期594-597,共4页 Chinese Journal of Ultrasonography
关键词 超声检查 前列腺肿瘤 前列腺增生症 前列腺特异抗原 Ultrasonography Prostatic neoplasms Prostatic hyperplasia Prostate-specific antigen
  • 相关文献

参考文献13

  • 1Loeb S, Catalona WJ. Prostate-specific antigen in clinical practice. Cancer Lett, 2007,249 : 30-39.
  • 2Benson MC,Whang IS,Pantuck A,et al. Prostate specific antigen density:a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol, 1992,147:815-816.
  • 3Kalish J, Cooner WH, Graham SD Jr. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume ( PSAD ) in detecting adenocarcinoma of the prostate. U rology, 1994,43 : 601-606.
  • 4Hodge KK, MeNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol, 1989,142:71-74.
  • 5Wang MC, Valenzuela I.A, Murphy GP, et al. Purification of a human prostate specific: antigen. Invest Urol, 1979,17 : 159-163.
  • 6Kang SH, Bae JH, Park HS, et al. Prostate specific antigen adjusted for tile transition zone volume as a second screening test:a prospective study of 248 cases. Int J Urol,2006, 13:910-914.
  • 7Kawai M,Okajima K,Kobayashi K,et al. Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations. Hinyokika Kiyo, 2006,52:113-117.
  • 8阮骊韬,郝志强,段云友,曹铁生,王作军,杨一林.经直肠超声研究移行区体积校正的前列腺特异性抗原浓度在前列腺癌诊断中的意义[J].中华超声影像学杂志,2005,14(3):212-214. 被引量:3
  • 9Veneziano S, Pavliea P, Compagnone G, et al. Usefulness of the (F/T)/PSA density ratio *o detect prostate cancer. Urol Int, 2005,74: 13-18.
  • 10韩刚,高江平,曹希亮,洪宝发,唐杰.游离前列腺特异抗原百分比/前列腺特异抗原密度在前列腺癌诊断中的应用[J].中华外科杂志,2006,44(6):379-381. 被引量:11

二级参考文献22

  • 1张尧,江军,靳凤烁,王洛夫,兰卫华.血清TPSA与F/T检测在前列腺良、恶性病变诊断中的价值及其影响因素[J].临床泌尿外科杂志,2005,20(3):153-155. 被引量:6
  • 2Garzotto M, Hudson RG, Peters L, et al. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels <10 ng/ml. Cancer,2003,98:1417-1422.
  • 3Shinohara K, Wheeler TM, Scardino PT. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol, 1989,142: 76-82.
  • 4Gustafsson O, Carlsson P, Norming U, et al. Cost-effectiveness analysis in early detection of prostate cancer :an evaluation of six screening strategies in a randomly selected population of 2400 men.Prostate, 1995,26 : 299-309.
  • 5Ruckle HC,Klee GG,Osterling JE. Prostate specific antigen critical issues for the practicing physician. Mayo Clin Proc, 1994, 69: 59-68.
  • 6Benson MC, Whang IS, Olsson CA, et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum PSA. J Urol, 1992,147:817-821.
  • 7Bazinet M, Meshref AW,Trudel C,et al. Prospective evaluation of prostate-specific antigen density and systemic biopsies for early detection of prostatic carcinoma. Urology, 1994,43:44-52.
  • 8Sung DJ,Cho SB,Kim YH,et al. Comparison of proastate specific antigen adjusted for transition zone volume versus prostate specific antigen density in predicting prostate cancer by transrectal ultrasonography. J Ultrasound Med, 2004,23:615-622.
  • 9Hammerer PG,McNeal JE,Stamey TA. Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol, 1995,153:111-114.
  • 10Kalish J,Cooner WH,Graham SD. Serum PSA adjusted for volume of transition zone(PSATZ) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology, 1994,43: 601-605.

共引文献12

同被引文献25

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部